Common Symptoms
Best initial test in a patient with low pretest probability for PE
D-dimer
Major benefit of NSAIDs in RA
Symptom control
IBD diagnostic test
Ileocolonoscopy with biopsy
Mnemonic for migraine characteristics
POUND (Pulsatile quality, One-day duration, Unilateral location, Nausea/vomiting, Disabling intensity)
Treatment duration for uncomplicated CAP with rapid clinical improvement
5 days
Initial drug therapy for acute low back pain
NSAIDs
Most specific serologic test for RA
Anti–cyclic citrullinated peptide antibody
Diagnosis suggested by fistula, perianal disease, strictures, abscess
Crohn disease
Most common cause of thunderclap headache
Subarachnoid hemorrhage
Rapid sensitive and specific test for C. difficile colitis
NAAT for C. difficile toxin genes
Most important components in the diagnostic evaluation of dyspnea
Detailed history and physical exam
Treatment of suspected giant cell arteritis
Immediate high-dose glucocorticoids
Treatment for all patients with Barrett esophagus
PPI and lifestyle changes (smoking cessation, weight loss)
Evaluation of first unprovoked seizure
MRI and EEG
Vaccination assessment following animal bite
Rabies and tetanus
Features that favor seizure in patient with syncope
Abnormal posturing, involuntary head turning, tongue laceration, auras, incontinence, prolonged post-episode confusion
Major cause of excess death in patients with RA
Coronary artery disease
Acute pancreatitis lab tests predicting poor outcome
Elevated hematocrit and BUN
Treatment of ischemic stroke–related symptomatic cerebral edema
Decompressive hemicraniectomy
First-line treatment for invasive aspergillosis
Mold-active triazole (voriconazole) or combination of mold-active triazole and echinocandin
Concomitant neurologic findings in patients with central vertigo secondary to vertebrobasilar stroke
Nystagmus, dysphagia, dysarthria, diplopia, ataxia, postural instability, hemiparesis, mental status changes
Inflammatory marker that may be normal in active SLE
C-reactive protein
Preferred diagnostic test for acute mesenteric ischemia
CTA
Management of unceasing convulsive status epilepticus after IV benzodiazepine and ASM
Intubation; anesthetically induced coma for 24-48 h (propofol, midazolam, or pentobarbital)
Induction therapy for cryptococcal meningitis
Lipid formulation of amphotericin B plus flucytosine